Primary Prevention of Stroke
2008; Lippincott Williams & Wilkins; Volume: 118; Issue: 9 Linguagem: Inglês
10.1161/circulationaha.108.800169
ISSN1524-4539
Autores Tópico(s)Cardiovascular Health and Risk Factors
ResumoHomeCirculationVol. 118, No. 9Primary Prevention of Stroke Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBPrimary Prevention of StrokeImpact of Healthy Lifestyle Philip B. Gorelick, MD, MPH Philip B. GorelickPhilip B. Gorelick From the Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago. Originally published26 Aug 2008https://doi.org/10.1161/CIRCULATIONAHA.108.800169Circulation. 2008;118:904–906After heart disease, stroke is the second leading cause of death worldwide in persons ≥15 years of age.1 Stroke was responsible for an estimated 5.7 millions deaths in 2005, with ≈87% of the deaths occurring in low- and middle-income countries. It is the fourth leading cause of disease burden as determined by disability-adjusted life-years. In the United States, stroke caused an estimated 1 in 16 deaths in 2004; ≈780 000 new or recurrent strokes occurred; and 15% to 30% of stroke survivors were permanently disabled.2 In the United States in 2008, the direct and indirect cost of stroke is estimated to be $65.5 billion. Globally, stroke death is anticipated to rise to 6.5 million in 2015 and 7.8 million in 2030.1 Although stroke poses a major public health challenge, it is preventable.3 Observational epidemiological studies and clinical trials have laid the groundwork for well-developed evidence-based stroke prevention guidelines.Article p 947The INTERHEART study helped to clarify the role of traditional cardiovascular risk factors in coronary heart disease among 15 152 cases of acute myocardial infarction and 14 820 controls in 52 countries on every inhabited continent.4 This important observational epidemiological study showed that for men and women, old and young, and in all areas of the world, 9 potentially modifiable factors accounted for >90% of the proportion of the risk of initial acute myocardial infarction. The factors were abnormal lipids; smoking; hypertension; diabetes; abdominal obesity; psychosocial factors; consumption of fruits, vegetables, and alcohol; and regular physical activity. Because coronary heart disease and stroke share common risk factors,5 a combination of healthy lifestyle factors also might influence stroke risk. There has been a relatively paucity of information, however, in this area of study.Primary Prevention of Stroke by Healthy Lifestyle: Study Design and ResultsIn this issue of Circulation, Chiuve et al6 report on the impact of a combination of healthy lifestyle factors on the risk of stroke and estimate the burden of stroke attributed to unhealthy lifestyle choices. Information on lifestyle habits and medical history was obtained primarily from white subjects enrolled in the Nurses' Health Study (NHS) and Health Professionals Follow-up Study (HPFS). These studies included 71 243 women and 43 685 men free of cardiovascular disease and cancer at baseline. The following healthy lifestyle factors were the main focus of the analysis: not smoking, diet, exercise, optimal body weight as defined by body mass index, and alcohol consumption. Standard epidemiological questionnaires were used to ascertain risk. Dietary information was obtained primarily from an expanded food-frequency questionnaire and a summary diet score according to the Alternate Healthy Eating Index. "Low risk" for lifestyle variables of interest is defined in Table 1. Strokes were categorized according to National Survey of Stroke criteria and were classified as ischemic, hemorrhagic, or unknown type. Table 1. Operational Definition of Low Risk for Lifestyle Study FactorsBMI indicates body mass index. Data derived from Chiuve et al.6*In secondary analyses, most recent BMI before stroke diagnosis was used. When low-risk BMI was defined as 18.5 to <25 kg/m2, the study results did not differ.Factor and definition Smoking: not currently smoking (former smokers included) Physical activity: ≥30 min/d of moderate or vigorous activity Diet: diet score in top 40% of each cohort distribution Moderate alcohol consumption: at least 5 g/d with an upper limit of 15 g/d for women and 30 g/d for men Optimal weight: BMI <25 kg/m2 during midlife (at baseline)*Overall, there were 1559 cases of stroke in women, of which 853 were ischemic, 278 were hemorrhagic, and 428 were of unknown type, in NHS and 994 cases of stroke in men, of which 600 were ischemic, 161 were hemorrhagic, and 233 were of unknown type, in HPFS.6 Twenty-five percent and 23% of total strokes requiring hospitalization but for which medical records were not available were designated as probable in NHS and HPFS, respectively. For both women and men who had all 5 low-risk factors, there was a dramatic reduction in total and ischemic stroke risk (Table 2). The associations between low-risk lifestyle factors and hemorrhagic stroke followed a pattern similar to that of ischemic stroke but were not as strong because the number of incident hemorrhagic strokes was low and the population-attributable risk percent estimates were unstable and had relatively wide confidence limits. Finally, for both women and men, total and ischemic strokes were significantly associated with adherence to a low-risk lifestyle (Table 2). The authors estimated that more than half of the ischemic strokes in either group could have been prevented if all had been in the low-risk healthy lifestyle group. Table 2. Relative Risk, Population-Attributable Risk Percent, and 95% CI for Lifestyle Study FactorsTotal StrokeIschemic StrokeRR indicates relative risk; PAR%, population-attributable risk percent. RR estimates are from Figure 1A and 1B and PAR% is from Table 3 of Chiuve et al.6*Compared with those who had none of the factors.RR by all 5 low-risk factors (95% CI)* Women0.21 (0.12–0.36)0.19 (0.09–0.40) Men0.31 (0.19–0.53)0.20 (0.10–0.42)PAR% by low-risk lifestyle, % (95% CI) Women47 (18–69)54 (15–78) Men35 (7–58)52 (19–75)Commentary and Interpretation of Study ResultsInterest in health, healthy living, and healthy environment has been fueled over time by rising prosperity and other factors.7 A major aim of health promotion and prevention is to maximize health ("compress" morbidity) during life rather than necessarily preventing the inevitable.8 Many now have come to expect successful prevention of stroke, coronary heart disease, and other cardiovascular diseases if proper lifestyle habits are followed and modifiable cardiovascular risk factors are controlled. Furthermore, we are reminded of the importance of lifestyle factors such as smoking and alcohol use that may explain inequalities in mortality in some regions of the world.9Lifestyle management may be an effective way to reduce or delay stroke and cardiovascular disease risk. A recently published study, for example, the Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme (EuroAction), has shown that multidisciplinary programs are a means to achieve potential for cardiovascular prevention in coronary heart disease and other high-risk patients. This may be accomplished through lifestyle management, management of blood pressure, maintenance of lipids and blood glucose at target levels, and prescription of cardioprotective drugs.10 In addition, group-based lifestyle interventions (eg, diet and exercise) over years may prevent or delay cardiovascular risks such as diabetes,11 and a culturally sensitive, enhanced care package may lead to some improvement in blood pressure and total cholesterol in type 2 diabetics.12 Whereas lifestyle management may be important to preventive efforts, as we age and risk factors such as high blood pressure and lipids become more pronounced, the addition of pharmacological treatment may be necessary.13A key message of the study by Chiuve et al6 is that those with all 5 low-risk lifestyle factors had a substantial reduction (≈80% for women and 70% to 80% for men) of total or ischemic stroke compared with those who had none of the factors.6 In addition, as the number of low-risk factors increased from 3 (not smoking, top 40% of Alternate Healthy Eating Index diet score, exercise ≥30 min/d) to 4 (addition of body mass index <25 kg/m2) to 5 (addition of alcohol 5 to 15 g/d), there was a stepwise increase in population-attributable risk percent from 34% to 41% to 54% in women and from 16% to 42% to 52% in men, respectively, for ischemic stroke. Similarly, in women and men, there was a stepwise increase in population-attributable risk percent as the number of low-risk factors increased for total stroke. Furthermore, when population-attributable risk percent was calculated using alternate definitions of low risk (eg, most recent rather than baseline body mass index, 0.1 g/d alcohol as the lower limit of low risk, Dietary Approaches to Stop Hypertension dietary scores, or 6-nutrient diet scores), results were consistent or comparable. Overall, the findings of benefit for low-risk lifestyle in this study6 were similar to those of other studies.14,15Healthy aging may be predicated at least in part on a low-risk cardiovascular disease profile.16 In the Honolulu Asia Aging Study (HAAS), exceptional survival, defined as survival to a specified age without incidence of 6 major chronic diseases and without physical and cognitive impairment, was associated with avoidance of overweight, hyperglycemia, hypertension, smoking, excessive alcohol consumption, and other factors in 85-year-old subjects.17 How common, however, is a low-risk profile in the community? In the present study, among the NHS subjects (women), 2% were at low risk for all 5 factors, and 4% were at low risk for none of the factors.6 In the HPFS (men), 2% were at low risk for all 5 factors, and 2% were at low risk for none of the factors.6 In a study involving 5 cohorts with low risk defined as serum cholesterol <200 mg/dL, blood pressure ≤120/80 mm Hg, and no current cigarette smoking, only ≈5% to 10% in the cohorts fell into the low-risk category.15 In HAAS, 2451 (42%) survived to 85 years of age, and 11% met the criteria for exceptional survival.17 Therefore, the existence of true low-risk persons in the community based on lifestyle and other cardiovascular risk factors may be uncommon. Because this seems to be the case and because the lifestyle and other modifiable antecedents of coronary heart disease and stroke are prevalent in the community,3–5,18 the complementary mass and high-risk approaches to prevention remain a reasonable course of action.7 As we better understand the role of age as a "modifiable" risk factor13 and the influence of interventions on early life, potentially harmful socioeconomic-related factors,19 we may be better positioned to ward off the development of key lifestyle and other cardiovascular risk factors.The Chronic Disease Action Group has provided a call to action to encourage, support, and monitor activity on the implementation of evidence-based efforts to achieve global, regional, and national programs to prevent and control chronic diseases.20 Central to a successful global strategy is emphasis on a few key modifiable risks for chronic disease. These include unhealthy diet, physical inactivity, and tobacco use. Evidence-based interventions for populations and individuals have emerged to control such factors and may be cost worthy. Multisectoral policies are advocated with long-term, sustainable action plans to empower individuals, families, and communities to change their behavior to a health-conscious one.20 Optimism exists for this strategy, especially as it applies to low- and middle-income countries, although additional integrated stepwise surveillance and health outcomes research are needed to solidify the approach.This carefully done, insightful, and highly relevant analysis by Chiuve et al has potential limitations, as pointed out by the authors, in areas such as measurement error in self-reported variables; nondifferential misclassification, which could underestimate true relative risk; residual confounding; and underestimation of the burden of unhealthy behavior.6 However, the data remain consistent with other studies,14,15 and these potential study limitations should not deter us from concluding, as the authors have, that a low-risk lifestyle profile is associated with a substantial reduction in stroke risk. Furthermore, one wonders what may have led to adherence to an overall low-risk lifestyle in the Chiuve et al study subjects and if this information can be applied to the community at large.Because the combined health benefits may be considerable for not smoking, consuming alcohol in moderation (if one chooses to), maintaining a proper diet, exercising regularly, and keeping weight down, a more challenging matter is to shift the risk profile of the community at large in this direction in a sustainable manner. It seems that only a relatively small percentage of us are able to maintain such a healthy lifestyle profile. There are many temptations for unhealthy lifestyle choices before us and counterforces that detract from health-promotion efforts. Therefore, we have a significant challenge in our midst before we can claim victory of achieving a remarkable record for healthy lifestyle factors in individuals and the population.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.DisclosuresDr Gorelick serves on and receives honoraria for participation on a safety committee for Norvartis (Aliskiren); on steering committees for Bayer for the ARRIVE trial; for Boehringer Ingelheim for the PRoFESS trial; for Brainsgate (sphenopalatine ganglion stimulator for acute ischemic stroke); for Pharm-D (neuroprotectant in acute ischemic stroke); for adjudication committees for Myriad, TAP, and Pfizer; for a data monitoring board for Statistical Collaborative; and as a consultant for Daiichyi Sankyo (olmesartan). He has lectured for and received honoraria from diaDexus and Boehringer Ingelheim.FootnotesCorrespondence to Philip B. Gorelick, MD, MPH, John S. Garvin Professor and Head, Director, Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 S Wood St, Room 855N, Chicago, IL 60612. E-mail [email protected] References 1 Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007; 6: 182–187.CrossrefMedlineGoogle Scholar2 Rosamond W, Flegal K, Furie K, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y, for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. AHA heart disease and stroke statistics: 2008 update. Circulation. 2008; 117: e25–e146.LinkGoogle Scholar3 Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldberg S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus from the National Stroke Association. JAMA. 1999; 281: 1111–1120.Google Scholar4 Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, for the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937–952.CrossrefMedlineGoogle Scholar5 Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke. 2006; 37: 1583–1633.LinkGoogle Scholar6 Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB. Primary prevention of stroke by healthy lifestyle. Circulation. 2008; 118: 947–954.LinkGoogle Scholar7 Rose G. The Strategy of Preventive Medicine. New York, NY: Oxford University Press; 1994: 1–138.Google Scholar8 Woolf SH. The power of prevention and what it requires. JAMA. 2008; 299: 2437–2439.CrossrefMedlineGoogle Scholar9 Mackenbach JP, Stirbu I, Roskam A-JR, Schaap MM, Menvielle G, Liensalu M, Kunst A, for the European Union Working Group on Socioeconomic Inequalities in Health. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008; 358: 2468–2481.CrossrefMedlineGoogle Scholar10 Wood DA, Kotseva K, Connolly S, Jennings C, Mead Jones A, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O, for the EUROACTION Study Group. Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomized controlled trial. Lancet. 2008; 371: 1999–2012.CrossrefMedlineGoogle Scholar11 Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Province Prevention Study: a 20-year follow-up study. Lancet. 2008; 371: 1783–1789.CrossrefMedlineGoogle Scholar12 Bellary S, O'Hare JP, Raymond NT, Gumber A, Mughai S, Szczepura A, Kumare S, Bennett AH, for the UKADS Study Group. Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomized controlled trial. Lancet. 2008; 371: 1769–1776.CrossrefMedlineGoogle Scholar13 Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008; 371: 1547–1549.CrossrefMedlineGoogle Scholar14 Kurth T, Moore SC, Gaziano JM, Kase CS, Stampfer MJ, Berger K, Buring JE. Healthy lifestyle and the risk of stroke in women. Arch Intern Med. 2006; 166: 1403–1409.CrossrefMedlineGoogle Scholar15 Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland P. Low risk-factor profile and long-term expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999; 282: 2012–2019.CrossrefMedlineGoogle Scholar16 Gorelick PB. William M. Feinberg lecture: cognitive vitality and the role of stroke and cardiovascular disease risk factors. Stroke. 2005; 36: 875–879.LinkGoogle Scholar17 Willcox BJ, He Q, Chen R, Yano K, Masaki KH, Grove JS, Donlon TA, Willcox DC, Curb DJ. Midlife risk factors and healthy survival in men. JAMA. 2006; 296: 2343–2350.CrossrefMedlineGoogle Scholar18 Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003; 290: 891–897.CrossrefMedlineGoogle Scholar19 William RB. Lower socioeconomic status and increased mortality: early childhood roots and potential successful interventions. JAMA. 1998; 279: 1745–1746.CrossrefMedlineGoogle Scholar20 Beaglehole R, Ebrahim S, Reddy S, Voute J, Leeder S, for the Chronic Disease Action Group. Prevention of chronic diseases: a call to action. Lancet. 2007; 370: 2152–2157.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited ByFeigin V, Owolabi M, Hankey G, Pandian J and Martins S (2022) Digital Health in Primordial and Primary Stroke Prevention: A Systematic Review, Stroke, 53:3, (1008-1019), Online publication date: 1-Mar-2022.Feigin V, Brainin M, Norrving B, Gorelick P, Dichgans M, Wang W, Pandian J, Martins S, Owolabi M, Wood D and Hankey G (2020) What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?, Journal of the American Heart Association, 9:3, Online publication date: 4-Feb-2020. Mahon S, Krishnamurthi R, Vandal A, Witt E, Barker-Collo S, Parmar P, Theadom A, Barber A, Arroll B, Rush E, Elder H, Dyer J and Feigin V (2017) Primary prevention of stroke and cardiovascular disease in the community (PREVENTS): Methodology of a health wellness coaching intervention to reduce stroke and cardiovascular disease risk, a randomized clinical trial, International Journal of Stroke, 10.1177/1747493017730759, 13:2, (223-232), Online publication date: 1-Feb-2018. Farooq M and Gorelick P (2017) Stroke Risk Factors☆ Reference Module in Neuroscience and Biobehavioral Psychology, 10.1016/B978-0-12-809324-5.03844-X, . Feigin V, Norrving B, George M, Foltz J, Roth G and Mensah G (2016) Prevention of stroke: a strategic global imperative, Nature Reviews Neurology, 10.1038/nrneurol.2016.107, 12:9, (501-512), Online publication date: 1-Sep-2016. Testai F and Gorelick P (2016) Vascular Cognitive Impairment and Alzheimer Disease: Are These Disorders Linked to Hypertension and Other Cardiovascular Risk Factors? Hypertension and Stroke, 10.1007/978-3-319-29152-9_15, (261-284), . Gorelick P (2015) Treatment: special conditions, Journal of the American Society of Hypertension, 10.1016/j.jash.2015.02.007, 9:4, (320-325), Online publication date: 1-Apr-2015. Gorelick P, Farooq M and Min J (2014) Population-based approaches for reducing stroke risk, Expert Review of Cardiovascular Therapy, 10.1586/14779072.2015.987128, 13:1, (49-56), Online publication date: 2-Jan-2015. Gorelick P (2014) Stroke Risk Factors Encyclopedia of the Neurological Sciences, 10.1016/B978-0-12-385157-4.00420-6, (326-328), . Krishnamurthi R, Jones K and Feigin V (2013) Risk factors and primary prevention Stroke Management and Recovery, 10.2217/ebo.12.477, (22-37), Online publication date: 1-Apr-2013. Schroeter T, Linke A, Haensig M, Merk D, Borger M, Mohr F and Schuler G (2012) Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation, Europace, 10.1093/europace/eus191, 14:12, (1759-1763), Online publication date: 1-Dec-2012. Testai F and Gorelick P (2011) Vascular Cognitive Impairment and Alzheimer Disease: Are These Disorders Linked to Hypertension and Other Cardiovascular Risk Factors? Hypertension and Stroke, 10.1007/978-1-60761-010-6_12, (195-210), . (2010) Abstracts, International Journal of Stroke, 10.1111/j.1747-4949.2010.00480.x, 5:2_suppl, (1-375), Online publication date: 1-Oct-2010. Hachinski V, Donnan G, Gorelick P, Hacke W, Cramer S, Kaste M, Fisher M, Brainin M, Buchan A, Lo E, Skolnick B, Furie K, Hankey G, Kivipelto M, Morris J, Rothwell P, Sacco R, Smith S, Wang Y, Bryer A, Ford G, Iadecola C, Martins S, Saver J, Skvortsova V, Bayley M, Bednar M, Duncan P, Enney L, Finklestein S, Jones T, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg M, Heiss W, Saarelma O, Schwamm L, Shinohara Y, Trivedi B, Wahlgren N, Wong L, Hakim A, Norrving B, Prudhomme S, Bornstein N, Davis S, Goldstein L, Leys D and Tuomilehto J (2010) Stroke: Working toward a Prioritized World Agenda, International Journal of Stroke, 10.1111/j.1747-4949.2010.00442.x, 5:4, (238-256), Online publication date: 1-Aug-2010. Erkapic D, Kim W, Weber M, Mollmann H, Berkowitsch A, Zaltsberg S, Pajitnev D, Rixe J, Neumann T, Kuniss M, Sperzel J, Hamm C and Pitschner H (2010) Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation, Europace, 10.1093/europace/euq094, 12:8, (1188-1190), Online publication date: 1-Aug-2010. Hachinski V, Donnan G, Gorelick P, Hacke W, Cramer S, Kaste M, Fisher M, Brainin M, Buchan A, Lo E, Skolnick B, Furie K, Hankey G, Kivipelto M, Morris J, Rothwell P, Sacco R, Smith S, Wang Y, Bryer A, Ford G, Iadecola C, Martins S, Saver J, Skvortsova V, Bayley M, Bednar M, Duncan P, Enney L, Finklestein S, Jones T, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg M, Heiss W, Saarelma O, Schwamm L, Shinohara Y, Trivedi B, Wahlgren N, Wong L, Hakim A, Norrving B, Prudhomme S, Bornstein N, Davis S, Goldstein L, Leys D and Tuomilehto J (2010) Stroke: Working Toward a Prioritized World Agenda, Stroke, 41:6, (1084-1099), Online publication date: 1-Jun-2010. Srikanth V, Sanders L, Callisaya M, Martin K and Phan T (2010) Brain aging and gait, Aging Health, 10.2217/ahe.09.79, 6:1, (123-131), Online publication date: 1-Feb-2010. Gorelick P and Ruland S (2010) Update of Cerebral Vascular Disease: Issues for the Primary Care Physician, Disease-a-Month, 10.1016/j.disamonth.2009.12.001, 56:2, (40-71), Online publication date: 1-Feb-2010. Biller J (2014) Expert Review of Neurotherapeutics : recent stroke highlights , Expert Review of Neurotherapeutics, 10.1586/14737175.9.2.175, 9:2, (175-178), Online publication date: 1-Feb-2009. Bauernschmitt R, Bleiziffer S, Ruge H, Mazzitelli D, Schreiber C, Tassani-Prell P, Hutter A, Opitz A, Libera P and Lange R (2009) Kathetergestützter Aortenklappenersatz: Alternative zur offenen Chirurgie bei HochrisikopatientenCatheter-based aortic valve replacement: Alternative to open surgery on high-risk patients, Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 10.1007/s00398-009-0678-0, 23:1, (2-8), Online publication date: 1-Feb-2009. August 26, 2008Vol 118, Issue 9 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.108.800169PMID: 18725502 Originally publishedAugust 26, 2008 Keywordslifestyleriskstroke preventionEditorialsPDF download Advertisement SubjectsPrimary Prevention
Referência(s)